A pack of 100 pen needles costs RUB 1,500 (USD 15 ... They switched to Fiasp, which worked well, but then they replaced it ...
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...
In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of Wegovy for children 12 and up in late 2022. The numbers of prescriptions of ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...
Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback